Silencing of <scp>lncRNA CRNDE</scp> attenuates nonsmall‐cell lung cancer progression by mediating the <scp>miR</scp> ‐455‐3p/ <scp>HDAC2</scp> axis-Reference-Cited by-同舟云学术

Silencing of lncRNA CRNDE attenuates nonsmall‐cell lung cancer progression by mediating the miR ‐455‐3p/ HDAC2 axis

Published:2022-05-25 Issue:8 Volume:38 Page:749-760
ISSN:1607-551X
Container-title:The Kaohsiung Journal of Medical Sciences
language:en
Short-container-title:The Kaohsiung J of Med Scie

Author:

Li Na¹²³,Chen Xiao‐Juan⁴,Zeng Yun‐Hui²,Zeng Li‐Ping²,Hu Ke²,Chen Li‐Jun²^ORCID

Affiliation:

1. Department of Pathology The Second Affiliated Hospital of Hunan University of Chinese Medicine Changsha Hunan Province China

2. Medical College, Hunan University of Medicine Huaihua Hunan Province China

3. Department of Pathology The First Affiliated Hospital of Hunan University of Medicine Huaihua Hunan Province China

4. Department of Clinical Laboratory Hunan Maternal and Child Care Hospital Changsha Hunan Province China

Publisher

Wiley

Subject

General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/kjm2.12558

Reference38 articles.

1. Inhibition of ACK1 delays and overcomes acquired resistance of EGFR mutant NSCLC cells to the third generation EGFR inhibitor, osimertinib

2. How specific molecular‑targeted agents can make obsolete a ‘one size fits all’ approach in EGFR‑mutated NSCLC treatment (Review)

3. Effect of lncRNA‐BLACAT1 on drug resistance of non‐small cell lung cancer cells in DDP chemotherapy by regulating cyclin D1 expression;Ju ZS;Eur Rev Med Pharmacol Sci,2020

4. Long non‑coding RNA B4GALT1‑Antisense RNA 1/microRNA‑30e/SRY‑box transcription factor 9 signaling axis contributes to non‑small cell lung cancer cell growth

5. Knockdown of lncRNA‐XIST enhances the chemosensitivity of NSCLC cells via suppression of autophagy;Sun W;Oncol Rep,2017

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. LncRNA XIST/miR-455-3p/HOXC4 axis promotes breast cancer development by activating TGF-β/SMAD signaling pathway;Functional & Integrative Genomics;2024-09-12

2. From diagnosis to therapy: The critical role of lncRNAs in hepatoblastoma;Pathology - Research and Practice;2024-08

3. Contribution of CRNDE lncRNA in the development of cancer and the underlying mechanisms;Pathology - Research and Practice;2023-04

4. HDAC2 as a target for developing anti-cancer drugs;Computational and Structural Biotechnology Journal;2023